Last Updated on October 15, 2024 by The Health Master
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA, Inc. is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets.
The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US market by Aurobindo Pharma USA, Inc.
As per the USFDA, the company is recalling the affected lot due to:
“Current good manufacturing practices (CGMP) deviations: detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.”
Nitrosamines are a group of compounds that can damage DNA in the long term. The company, a unit of Hyderabad-based Aurobindo Pharma, initiated the class-II voluntary recall on 5th October this year.
In a separate statement, the USFDA said AuroMedics Pharma, a unit of Aurobindo Pharma, is recalling 11,520 units of Fondaparinux Sodium Injection in the US market.
The medication, an anticoagulant, is used in the treatment of deep vein thrombosis.
As per the USFDA, the company is recalling the affected units due to:
It is “Subpotent Drug: Out of specification for assay.”
AuroMedics Pharma initiated Class II recall for the affected lot across the US on September 30th of this year.
Drug recall: These products recalled by Dr Reddy’s, Cipla, and Aurobindo
Drug recall: Sodium Bicarbonate Injection recalled due to this reason
Drug recall: Acyclovir Sodium Injection recalled due to this reason
Drug recall: Zydus, Lupin recall products due to this issue
Drug recall: Glenmark, Strides Pharma, Cipla recalled these drugs
Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs
Lab-made Blood given to people in world-first Clinical Trial
USFDA gives tentative approval for Drospirenone tablets
IPC adds 10 new Impurity Reference Substances to IP 2022
USFDA issues warning letter to Lupin API plant
NPPA to consider Retail Price Fixation of this Asthma Drug Combination
USFDA approves Ketorolac Tromethamine injection
300 Drug Formulations to have mandatory Bar Codes
USFDA gives final approval for Sodium Phenylbutyrate tablets
IPC clarifies on uniformity of dosage units & impurities in IP 2022
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
